{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:47:57Z","timestamp":1767707277544},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/bor.0000000000000026","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T04:40:15Z","timestamp":1389674415000},"page":"111-117","source":"Crossref","is-referenced-by-count":16,"title":["Incidence of lymphoma associated with underlying lupus"],"prefix":"10.1097","volume":"26","author":[{"given":"Tanmayee","family":"Bichile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","article-title":"An international cohort study of cancer in SLE.","volume":"52","author":"Bernatsky","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multicentre cohort study.","volume":"42","author":"Bernarsky","year":"2013","journal-title":"J Autoimmun"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID): a potential RNA editing enzyme.","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1182\/blood.V74.6.1876.1876","article-title":"K. t(3;22)(q27;q11): a novel translocation associated with diffuse non-Hodgkins lymphoma.","volume":"74","author":"Offit","year":"1989","journal-title":"Blood"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood.V79.10.2527.2527","article-title":"Translocations involving band 3q27 and Ig gene regions in non-Hodgkins lymphoma.","volume":"79","author":"Bastard","year":"1992","journal-title":"Blood"},{"key":"R8-3-20210128","first-page":"2732","article-title":"Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma.","volume":"53L","author":"Ye","year":"1993","journal-title":"Cancer Res"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"12520","DOI":"10.1073\/pnas.92.26.12520","article-title":"Frequent somatic hypermutation of the 5 noncoding region of the BCL6 gene in B-cell lymphoma.","volume":"92","author":"Migliazza","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-3-20210128","first-page":"1803","article-title":"Pathogenesis of non-Hodgkins lymphoma.","volume":"29","author":"Hendrik","year":"2011","journal-title":"Clin Oncol"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2006.04.004","article-title":"BAFF, APRIL and human B cell disorders.","volume":"18","author":"Tangye","year":"2006","journal-title":"Semin Immunol"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","article-title":"Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.","volume":"44","author":"Cheema","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.166.1.6","article-title":"Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.","volume":"166","author":"Zhang","year":"2001","journal-title":"J Immunol"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2004.022491","article-title":"Raised serum APRIL levels in patients with systemic lupus erythematosus.","volume":"64","author":"Koyama","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3899\/jrheum.101190","article-title":"Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.","volume":"3","author":"Lofstrom","year":"2011","journal-title":"J Rheumatol"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2004-02-0762","article-title":"Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.","volume":"104","author":"Novak","year":"2004","journal-title":"Blood"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.4049\/jimmunol.171.10.5215","article-title":"EBV-encoded latent membrane protein 1 cooperates with BAFFBLyS and APRIL to induce T cell-independent Ig heavy chain class switching.","volume":"171","author":"He","year":"2003","journal-title":"J Immunol"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk.","volume":"32A","author":"Mellemkjaer","year":"1996","journal-title":"Eur J Cancer"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions.","volume":"88","author":"Thomas","year":"2000","journal-title":"Int J Cancer"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","article-title":"Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/B:CACO.0000027506.55846.5d","article-title":"Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women.","volume":"15","author":"Zhang","year":"2004","journal-title":"Cancer Causes Control"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/rheumatology\/ken130","article-title":"Cancer risk in hospitalized rheumatoid arthritis patients.","volume":"47","author":"Hemminki","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1018472213872","article-title":"Elevated incidence of hematologic malignancies in patients with Sjogrens syndrome compared with patients with rheumatoid arthritis (Finland).","volume":"8","author":"Kauppi","year":"1997","journal-title":"Cancer Causes Control"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogrens syndrome.","volume":"46","author":"Ionnidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/kep404","article-title":"Incidence of malignancy in primary Sjogrens syndrome in a Chinese cohort.","volume":"49","author":"Zhang","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/gast.2002.36585","article-title":"Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis.","volume":"123","author":"Askling","year":"2002","journal-title":"Gastroenterology"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/bmj.38169.486701.7C","article-title":"Malignancy and mortality in people with coeliac disease: population based cohort study.","volume":"329","author":"West","year":"2004","journal-title":"BMJ"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-230X-7-8","article-title":"Delayed diagnosis of coeliac disease increases cancer risk.","volume":"7","author":"Silano","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"R29-3-20210128","first-page":"1085","article-title":"Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland.","volume":"76","author":"Kato","year":"1985","journal-title":"Jpn J Cancer Res"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJM198503073121001","article-title":"Cancer risks in patients with chronic lymphocytic thyroiditis.","volume":"312","author":"Holm","year":"1985","journal-title":"N Engl J Med"},{"key":"R31-3-20210128","first-page":"461","article-title":"Auto-antibodies in early breast cancer: a stage related phenomenon Br J C","volume":"38","author":"Turnbull","year":"1978","journal-title":"ancer"},{"key":"R32-3-20210128","first-page":"417","article-title":"Autoantibodies in patients with carcinoma of breast: correlation with prognosis.","volume":"19","author":"Wasserman","year":"1975","journal-title":"Clin Exp Immunol"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(72)92453-1","article-title":"Malignancy associated with antinuclear antibodies.","volume":"2","author":"Zeromski","year":"1972","journal-title":"Lancet"},{"key":"R34-3-20210128","first-page":"1372","article-title":"Antinuclear, antinucleolar and anticytoplasmatic antibodies in patients with malignant melanoma.","volume":"43","author":"Thomas","year":"1983","journal-title":"Cancer Res"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000250557","article-title":"Circulating antibodies in malignant melanoma patients.","volume":"159","author":"Betterle","year":"1979","journal-title":"Dermatologica"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.1840050405","article-title":"The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma.","volume":"5","author":"Kiosawa","year":"1985","journal-title":"Hepatology"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0090-1229(75)90006-9","article-title":"Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases.","volume":"4","author":"Steiner","year":"1975","journal-title":"Clin Immunol Immunopathol"},{"key":"R38-3-20210128","first-page":"753","article-title":"Autoantibodies, autoimmunity and cancer.","volume":"5","author":"Tomer","year":"1998","journal-title":"Oncol Rep"},{"key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R40-3-20210128","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2004.034504","article-title":"Non-Hodgkins lymphoma in systemic lupus erythematosus.","volume":"64","author":"Bernatsky","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R41-3-20210128","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/ard.2006.067108","article-title":"A closer look at non-Hodgkins lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case control study.","volume":"66","author":"Lofstrom","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R42-3-20210128","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10067-006-0532-7","article-title":"Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkins lymphoma (NHL).","volume":"26","author":"King","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R43-3-20210128","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood.V99.4.1136","article-title":"Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma.","volume":"99","author":"Barrans","year":"2002","journal-title":"Blood"},{"key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2002-04-1286","article-title":"Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.","volume":"101","author":"Colomo","year":"2003","journal-title":"Blood"},{"key":"R45-3-20210128","first-page":"722","article-title":"Immunohistochemical expression of CD23 and CD40 may identify prognostically favourable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study.","volume":"9","author":"Linderoth","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R46-3-20210128","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00000478-200404000-00005","article-title":"Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.","volume":"28","author":"Chang","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R47-3-20210128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R48-3-20210128","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/modpathol.3800396","article-title":"Evaluation of immunophenotype in diffuse large B-cell lymphoma and impact on prognosis.","volume":"18","author":"Berglund","year":"2005","journal-title":"Mod Pathol"},{"key":"R49-3-20210128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/ard.51.4.437","article-title":"Increased risk of cancer in patients with systemic lupus erythematosus.","volume":"51","author":"Pettersson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"R50-3-20210128","first-page":"1478","article-title":"Risk of malignancy in women with SLE.","volume":"22","author":"Sweeney","year":"1995","journal-title":"J Rheumatol"},{"key":"R51-3-20210128","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/art.1780390625","article-title":"Malignancy in systemic lupus erythematosus.","volume":"39","author":"Abu-Shakara","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R52-3-20210128","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780400424","article-title":"Non-Hodgkins lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.","volume":"40","author":"Mellemkjaer","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R53-3-20210128","first-page":"217","article-title":"Increased risk of malignancy in patients with systemic lupus erythematosus.","volume":"46","author":"Ramsey-Goldman","year":"1998","journal-title":"J Investig Med"},{"key":"R54-3-20210128","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/rheumatology\/39.10.1147","article-title":"Is there an association of malignancy in systemic lupus erythematosus An analysis of 276 patients under long term review.","volume":"39","author":"Sultan","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"R55-3-20210128","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1191\/096120301701548481","article-title":"Systemic lupus erythematosus and B-cell hematologic neoplasm.","volume":"10","author":"Xu","year":"2001","journal-title":"Lupus"},{"key":"R56-3-20210128","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1191\/096120301678416079","article-title":"Malignancies during follow-up in an epidemiologically defined SLE inception cohort in southern Sweden.","volume":"10","author":"Nived","year":"2001","journal-title":"Lupus"},{"key":"R57-3-20210128","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","article-title":"Systemic lupus erythematosus and risk of malignancy.","volume":"10","author":"Cibere","year":"2001","journal-title":"Lupus"},{"key":"R58-3-20210128","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/03009740252937568","article-title":"Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.","volume":"31","author":"Bjornadal","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"R59-3-20210128","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1191\/0961203303lu443oa","article-title":"Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.","volume":"12","author":"Ragnarsson","year":"2003","journal-title":"Lupus"},{"key":"R60-3-20210128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment.","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R61-3-20210128","first-page":"2551","article-title":"The prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues and obesity.","volume":"29","author":"Bernatsky","year":"2002","journal-title":"J Rheumatol"},{"key":"R62-3-20210128","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","article-title":"The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.","volume":"142","author":"Buyon","year":"2005","journal-title":"Ann Intern Med"},{"key":"R63-3-20210128","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1200\/JCO.2001.19.5.1381","article-title":"Reproductive factors and risk of intermediate or high grade B-cell non-Hodgkins lymphoma in women.","volume":"19","author":"Nelson","year":"2001","journal-title":"J Clin Oncol"},{"key":"R64-3-20210128","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1023\/B:CACO.0000043427.77739.60","article-title":"Tobacco and alcohol consumption and risk of non-Hodgkin lymphoma.","volume":"15","author":"Willett","year":"2003","journal-title":"Cancer Causes Control"},{"key":"R65-3-20210128","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1002\/art.20616","article-title":"Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection.","volume":"11","author":"Tam","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R66-3-20210128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3899\/jrheum.090644","article-title":"Natural history of cervical papilloma virus infection in systemic lupus erythematosus: a prospective cohort study.","volume":"37","author":"Tam","year":"2010","journal-title":"J Rheumatol"},{"key":"R67-3-20210128","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/art.30483","article-title":"High incidence of potentially virus induced malignancies in systemic lupus erythematosus.","volume":"63","author":"Dreyer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R68-3-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.2006.069039","article-title":"The relationship between cancer and medication exposures in systemic lupus erythematosus: a case-cohort study.","volume":"67","author":"Bernatsky","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R69-3-20210128","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R70-3-20210128","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00002281-200405000-00014","article-title":"Rheumatoid arthritis and malignant lymphomas.","volume":"16","author":"Baecklund","year":"2004","journal-title":"Curr Opinion Rheumatol"},{"key":"R71-3-20210128","first-page":"188","article-title":"Inflammatory activity, but not methotrexate or prednisone use predicts non-Hodgkins lymphoma in rheumatoid arthritis: a 25 year study if 1767 RA patients.","volume":"41","author":"Wolfe","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R72-3-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-120-1-199401010-00006","article-title":"Incidence of cancer among men with the Felty syndrome.","volume":"120","author":"Gridley","year":"1994","journal-title":"Ann Intern Med"},{"key":"R73-3-20210128","first-page":"S91","article-title":"Risk of malignancy in cyclophosphamide treated SLE patients.","volume":"26","author":"Pryor","year":"1993","journal-title":"Arthritis Rheum"},{"key":"R74-3-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/ard.61.5.409","article-title":"Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades.","volume":"61","author":"Moss","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R75-3-20210128","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sjogrens syndrome: a multicenter retrospective, clinical study by the European Concerted Action on Sjogrens Syndrome.","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R76-3-20210128","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogrens syndrome: a cohort study on cancer incidence and lymphoma predictors.","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R77-3-20210128","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00004728-200307000-00011","article-title":"Clinical and imaging findings of lymphoma in patients with Sjogrens syndrome.","volume":"27","author":"Tonami","year":"2003","journal-title":"J Comput Assist Tomogr"},{"key":"R78-3-20210128","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"key":"R79-3-20210128","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/rheumatology\/kel444","article-title":"Hodgkins lymphoma in systemic lupus erythematosus.","volume":"46","author":"Bernatsky","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R80-3-20210128","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.","volume":"98","author":"Landgren","year":"2006","journal-title":"J Natl Cancer Inst"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:31:35Z","timestamp":1620948695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201403000-00003"}},"subtitle":["lessons learned from observational studies"],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000026","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}